(PharmaNewsWire.Com, October 17, 2019 ) Chinese economic development has been a significant factor in determining the shift of Chinese families to In-Vitro fertilization (IVF) when it comes to parenthood. The introduction of China's two-child policy in October 2015, Chinese women's desire to have the opportunity to focus on their careers first and later in their lives on pregnancy, or to have a child even as single parents, are all key factors behind the growing demand for IVF services in China. China In Vitro Fertilization market is expected to be more than US$ 2.8 Billion by 2025.
Because of financial advancement and globalization, the lifestyle of the urban Chinese family has altered. Most females delay marriage and have kids, which makes it more difficult for couples to naturally conceive. Besides, it has been revealed that men now have a substantial decrease in sperm count in high-density urban regions due to high rates of stress and pollution. It is worth noting that China's average marriage age was 23 in the 1970s, 24 in the 1990s, and the 21st century it has risen to 27.
In the last few years, the demand for Assisted Reproductive Techniques (ART) has grown many folds. The primary cause of the rise in ARTS is infertility among patients. ARTS is triggering due to fast lifestyle change, smoking, drinking, steroids, mental stress/trauma, and other medical conditions such as diabetes, cystic fibrosis, trauma, testicular failure, and Fallopian blockage of the tube, female ovarian dysfunction, etc. These variables, therefore, are supporting the China IVF market growth and development.
Global healthcare firms are the major IVF services firms in China. These firms have a "passive" company model, although they integrate relationships with tour agents and referral offices. Tapping into this increasing demand for IVF services in China has become a significant chance for overseas firms to explore fresh markets in medical care.
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.
About Us
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys, and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. Our clients rely on our market analysis and data to make informed knowledgeable decisions. Our pertinent analysis helps consultants, bankers and executives to make informed and correct decisions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
